Welcome to our dedicated page for Camden Natl SEC filings (Ticker: CAC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Camden National Corporation SEC filings document formal disclosures for a publicly traded bank holding company and its community banking operations. Material-event reports furnish quarterly and annual earnings releases, dividend declarations, share repurchase authorization, and investor presentation materials.
The company’s proxy filings cover governance and executive-compensation matters, including equity awards and pension-related compensation measures. Together, the filings record Camden National’s reported operating results, capital-return actions, common-stock matters, board oversight, and public-company reporting obligations.
Martel William H reported acquisition or exercise transactions in this Form 4 filing.
Camden National Corp EVP William H. Martel received a grant of 1,064 shares of common stock as restricted stock units under the company’s 2023-2025 Long-Term Performance Share Plan. The award carries no purchase price and is scheduled to vest on April 25, 2026, contingent on continued employment. After this grant, Martel directly holds 21,355 shares of common stock, including 8,588 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions. This filing reflects equity-based compensation rather than an open-market share purchase or sale.
Camden National Corp EVP Barbara Raths received a stock-based compensation award. She acquired 551 restricted stock units under the company’s 2023-2025 Long-Term Performance Share Plan, at no cash price. The units are scheduled to vest on April 25, 2026, subject to continued employment.
Each restricted stock unit converts into one share of common stock at vesting. After this grant, she beneficially owns 8,496 shares of Camden National common stock, including 5,828 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions.
Smith Ryan A reported acquisition or exercise transactions in this Form 4 filing.
Camden National Corp EVP Ryan A. Smith received a grant of 1,015 restricted stock units of common stock at no cash cost. The units were awarded under the issuer's 2023-2025 Long-Term Performance Share Plan and are scheduled to vest on April 25, 2026, subject to continued employment.
Each restricted stock unit represents the right to receive one share of common stock upon vesting. After this award, Smith directly holds 23,413 shares of common stock, including 7,852 restricted stock units and restricted shares that remain subject to vesting and forfeiture restrictions.
Archer Michael R reported acquisition or exercise transactions in this Form 4 filing.
Camden National Corp EVP Michael R. Archer received a grant of 967 shares of common stock in the form of restricted stock units as compensation. These units were awarded at no cash cost and are scheduled to vest on April 25, 2026, if he remains employed through that date.
After this grant, Archer holds a total of 19,815.073 shares of common stock directly, including 9,157 restricted stock units and restricted shares that are still subject to vesting and forfeiture conditions.
Smyth Renee reported acquisition or exercise transactions in this Form 4 filing.
Camden National Corp executive vice president Renee Smyth received a grant of 896 restricted stock units as equity compensation. These units were awarded at no cash cost and are scheduled to vest on April 25, 2026, contingent on continued employment. Following this grant, Smyth directly holds 28,733.604 shares of common stock, including 6,925 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions.
Rose Patricia A reported acquisition or exercise transactions in this Form 4 filing.
Camden National Corp EVP Patricia A. Rose received a grant of 1,029 restricted stock units of common stock at no cash cost. The award was made under the company’s 2023-2025 Long-Term Performance Share Plan and is scheduled to vest on April 25, 2026, if she remains employed through that date.
Each restricted stock unit represents the right to receive one share of common stock at vesting. After this grant, she directly owns a total of 28,066.593 shares of common stock, including 5,257 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions.
CAMDEN NATIONAL CORP EVP David Ackley received an equity award of 725 restricted stock units of common stock. The award was granted under the company’s 2023-2025 Long-Term Performance Share Plan and is scheduled to vest on April 25, 2026, if he remains employed through that date.
Each restricted stock unit converts into one share of common stock at vesting. After this grant, Ackley directly owns a total of 12,846.958 shares of common stock, including 6,150 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions.
Camden National Corp EVP David Ackley received an equity grant of 725 restricted stock units under the company’s 2023-2025 Long-Term Performance Share Plan. The units are scheduled to vest on April 25, 2026, if he remains employed through that date, and each unit converts into one share of common stock at vesting.
After this award, Ackley directly holds a total of 12,846.958 shares of common stock, which includes 6,150 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions. This is a compensation-related, non‑open‑market acquisition rather than a market purchase.
The Vanguard Group amended its Schedule 13G for Camden National Corp common stock, reporting 0 shares beneficially owned representing 0% of the class. The filing explains an internal realignment effective January 12, 2026, under SEC Release No. 34-39538 that caused separate reporting by Vanguard subsidiaries.
Camden National Corp director Carl John Soderberg reported an equity award of 350 shares of Common Stock, acquired as a grant in lieu of director fees. The shares were awarded at a reportable price of $45.26 per share under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment.
Following this award, Soderberg directly holds 103,122.218 Common shares. A footnote also notes that 910.801 shares have been acquired since the last filing through participation in the company's dividend reinvestment program, illustrating ongoing accumulation of stock through automatic mechanisms rather than open‑market purchases.